View Document Preview and Link Open Document File Size: 102,11 KB Share Result on Facebook
City Hazelwood / Beltsville / MACMIS / / Company Mallinckrodt Inc. / Palatin Technologies Inc. / Steven Hanley President Imaging Division Mallinckrodt Inc. / / Event FDA Phase / / / IndustryTerm food allergies / magnetic resonance imaging / less dilute solutions / contrast media / hypertonic solutions / imaging / oral contrast media / / MedicalCondition serious pulmonary complications / headache / sickle cell anemia / Nausea / mucosal irritation / hyperthyroidism / tracheoesophageal fistula / respiratory disorders / food allergies / pulmonary edema / hay fever / diarrhea / pneumonitis / clinical hypersensitivity / multinodular goiters / hypotension / asthma / hemoglobinopathies / bronchial asthma / cardiac arrhythmias / allergy / seizure / vomiting / renal insufficiency / thyroid storm / dizziness / paresthesia / / MedicalTreatment rehydration / / Organization Food and Drug Administration / Division of Drug Marketing / Advertising / and Communications / Rectal administration / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH / / Person Thomas Abrams / / Position Market leader / PRECAUTIONS General / Director / representative / / Product Diatrizoate Meglumine / Tramadol Hydrochloride / Technetium / Diatrizoate / OptiMARK / MD-GASTROVIEW / Gadoversetamide Injection / OptiMARK® Injection / MD-GASTROVIEW® / OptiMARK® (Gadoversetamide Injection) / / ProvinceOrState Maryland / Missouri / / Technology tomography / MRI / magnetic resonance imaging / / SocialTag 
MD-GASTROVIEW® (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP)